- Home
- SBFM vs PMAX Comparison
SBFM vs PMAX Comparison
Compare SBFM & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBFM | PMAX |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 2.7M |
| IPO Year | 2008 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SBFM | PMAX |
|---|---|---|
| Price | $1.20 | $1.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 422.8K | 186.4K |
| Earning Date | 04-03-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,305,891.00 | N/A |
| Revenue This Year | $40.47 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.11 | N/A |
| 52 Week Low | $0.25 | $0.20 |
| 52 Week High | $3.05 | $5.20 |
Technical Indicators
Market Signals| Indicator | SBFM | PMAX |
|---|---|---|
| Relative Strength Index (RSI) | 32.50 | N/A |
| Support Level | $1.13 | N/A |
| Resistance Level | $1.28 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 17.02 | 0.00 |
Price Performance
Historical ComparisonAbout SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About PMAX Powell Max Limited
Powell Max Ltd operates as a financial communications platform supporting listed companies and IPO applicants throughout the capital markets lifecycle. Substantially all of the company's revenue is generated from Hong Kong. The group focused on supporting the disclosure, reporting, and transaction needs of corporate clients and their advisors. Its mission is to combine industry knowledge, execution capabilities, and a commitment to service to deliver accurate, timely, and reliable solutions for customers.